193 related articles for article (PubMed ID: 34587909)
1. Linear and non-linear analysis of heart rate variability in HIV-positive patients on two different antiretroviral therapy regimens.
Gonçalves AJ; Braga MVA; Santana PH; Resende LAPR; da Silva VJD; Correia D
BMC Infect Dis; 2021 Sep; 21(1):1022. PubMed ID: 34587909
[TBL] [Abstract][Full Text] [Related]
2. Power spectral analysis of heart rate variability in HIV-infected and AIDS patients.
Correia D; Rodrigues De Resende LA; Molina RJ; Ferreira BD; Colombari F; Barbosa CJ; Da Silva VJ; Prata A
Pacing Clin Electrophysiol; 2006 Jan; 29(1):53-8. PubMed ID: 16441718
[TBL] [Abstract][Full Text] [Related]
3. Abacavir-based triple nucleoside regimens for maintenance therapy in patients with HIV.
Cruciani M; Mengoli C; Serpelloni G; Parisi SG; Malena M; Bosco O
Cochrane Database Syst Rev; 2013 Jun; (6):CD008270. PubMed ID: 23740608
[TBL] [Abstract][Full Text] [Related]
4. Antiretroviral treatment outcome following genotyping in Thai children who failed dual nucleoside reverse transcriptase inhibitors.
Bunupuradah T; Suntarattiwong P; Li A; Sirivichayakul S; Pancharoen C; Boonrak P; Puthanakit T; Kerr SJ; Ruxrungtham K; Chotpitayasunondh T; Hirschel B; Ananworanich J;
Int J Infect Dis; 2010 Apr; 14(4):e311-6. PubMed ID: 19699673
[TBL] [Abstract][Full Text] [Related]
5. Efavirenz or nevirapine in three-drug combination therapy with two nucleoside or nucleotide-reverse transcriptase inhibitors for initial treatment of HIV infection in antiretroviral-naïve individuals.
Mbuagbaw L; Mursleen S; Irlam JH; Spaulding AB; Rutherford GW; Siegfried N
Cochrane Database Syst Rev; 2016 Dec; 12(12):CD004246. PubMed ID: 27943261
[TBL] [Abstract][Full Text] [Related]
6. Linear and nonlinear parameters of heart rate variability in ischemic stroke patients.
Constantinescu V; Matei D; Costache V; Cuciureanu D; Arsenescu-Georgescu C
Neurol Neurochir Pol; 2018 Mar; 52(2):194-206. PubMed ID: 29110883
[TBL] [Abstract][Full Text] [Related]
7. Decreased heart rate variability in HIV positive patients receiving antiretroviral therapy: importance of blood glucose and cholesterol.
Askgaard G; Kristoffersen US; Mehlsen J; Kronborg G; Kjaer A; Lebech AM
PLoS One; 2011; 6(5):e20196. PubMed ID: 21655281
[TBL] [Abstract][Full Text] [Related]
8. Efavirenz or nevirapine in three-drug combination therapy with two nucleoside-reverse transcriptase inhibitors for initial treatment of HIV infection in antiretroviral-naïve individuals.
Mbuagbaw LC; Irlam JH; Spaulding A; Rutherford GW; Siegfried N
Cochrane Database Syst Rev; 2010 Dec; (12):CD004246. PubMed ID: 21154355
[TBL] [Abstract][Full Text] [Related]
9. Influence of antiretroviral therapy on oxidative stress and cardiovascular risk: a prospective cross-sectional study in HIV-infected patients.
Masiá M; Padilla S; Bernal E; Almenar MV; Molina J; Hernández I; Graells ML; Gutiérrez F
Clin Ther; 2007 Jul; 29(7):1448-55. PubMed ID: 17825696
[TBL] [Abstract][Full Text] [Related]
10. A comparison of three highly active antiretroviral treatment strategies consisting of non-nucleoside reverse transcriptase inhibitors, protease inhibitors, or both in the presence of nucleoside reverse transcriptase inhibitors as initial therapy (CPCRA 058 FIRST Study): a long-term randomised trial.
MacArthur RD; Novak RM; Peng G; Chen L; Xiang Y; Hullsiek KH; Kozal MJ; van den Berg-Wolf M; Henely C; Schmetter B; Dehlinger M; ;
Lancet; 2006 Dec; 368(9553):2125-35. PubMed ID: 17174704
[TBL] [Abstract][Full Text] [Related]
11. Heart Rate Variability, HIV and the Risk of Cardiovascular Diseases in Rural South Africa.
Godijk NG; Vos AG; Jongen VW; Moraba R; Tempelman H; Grobbee DE; Coutinho RA; Devillé W; Klipstein-Grobusch K
Glob Heart; 2020 Feb; 15(1):17. PubMed ID: 32489790
[TBL] [Abstract][Full Text] [Related]
12. Impact of antiretroviral choice on hypercholesterolaemia events: the role of the nucleoside reverse transcriptase inhibitor backbone.
Jones R; Sawleshwarkar S; Michailidis C; Jackson A; Mandalia S; Stebbing J; Bower M; Nelson M; Gazzard BG; Moyle GJ
HIV Med; 2005 Nov; 6(6):396-402. PubMed ID: 16268821
[TBL] [Abstract][Full Text] [Related]
13. Autonomic modulation following exercise is impaired in HIV patients.
Borges J; Soares P; Farinatti P
Int J Sports Med; 2012 Apr; 33(4):320-4. PubMed ID: 22261827
[TBL] [Abstract][Full Text] [Related]
14. Time spent with residual viraemia after virological suppression below 50 HIV-RNA copies/mL according to type of first-line antiretroviral regimen.
Gianotti N; Galli L; Galizzi N; Ripa M; Andolina A; Nozza S; Spagnuolo V; Poli A; Lazzarin A; Castagna A
Int J Antimicrob Agents; 2018 Oct; 52(4):492-499. PubMed ID: 30009958
[TBL] [Abstract][Full Text] [Related]
15. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
Van Vaerenbergh K
Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
[TBL] [Abstract][Full Text] [Related]
16. Tenofovir or zidovudine in three-drug combination therapy with one nucleoside reverse transcriptase inhibitor and one non-nucleoside reverse transcriptase inhibitor for initial treatment of HIV infection in antiretroviral-naïve individuals.
Spaulding A; Rutherford GW; Siegfried N
Cochrane Database Syst Rev; 2010 Oct; (10):CD008740. PubMed ID: 20927777
[TBL] [Abstract][Full Text] [Related]
17. Different immunologic profiles characterize HIV infection in highly active antiretroviral therapy-treated and antiretroviral-naïve patients with undetectable viraemia. The Master Group.
Clerici M; Seminari E; Suter F; Castelli F; Pan A; Biasin M; Colombo F; Trabattoni D; Maggiolo F; Carosi G; Maserati R
AIDS; 2000 Jan; 14(2):109-16. PubMed ID: 10708280
[TBL] [Abstract][Full Text] [Related]
18. NNRTI plus PI combinations in the perspective of nucleoside-sparing or nucleoside-failing antiretroviral regimens.
Joly V; Descamps D; Yeni P
AIDS Rev; 2002; 4(3):128-39. PubMed ID: 12416447
[TBL] [Abstract][Full Text] [Related]
19. A meta-analysis of HIV and heart rate variability in the era of antiretroviral therapy.
McIntosh RC
Clin Auton Res; 2016 Aug; 26(4):287-94. PubMed ID: 27395409
[TBL] [Abstract][Full Text] [Related]
20. Autonomic dysfunction in HIV patients on antiretroviral therapy: studies of heart rate variability.
Lebech AM; Kristoffersen US; Mehlsen J; Wiinberg N; Petersen CL; Hesse B; Gerstoft J; Kjaer A
Clin Physiol Funct Imaging; 2007 Nov; 27(6):363-7. PubMed ID: 17944658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
